» Articles » PMID: 21081571

Screening for Atherosclerotic Plaques in the Abdominal Aorta in High-risk Patients with Multicontrast-weighted MRI: a Prospective Study at 3.0 and 1.5 Tesla

Overview
Journal Br J Radiol
Specialty Radiology
Date 2010 Nov 18
PMID 21081571
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This prospective study compares MRI of atherosclerotic plaque in the abdominal aorta at 3 T with that at 1.5 T in patients suffering from hereditary hyperlipidaemia, a major risk factor for atherosclerosis.

Methods: MRI of the abdominal aorta at 1.5 and 3 T was performed in 21 patients (mean age 58 years). The study protocol consisted of proton density (PD), T(1), T(2) and fat-saturated T(2) weighted black blood images of the abdominal aorta in corresponding orientation. Two independent radiologists performed image rating. First, image quality was rated on a five-point scale. Second, atherosclerotic plaques were scored according to the modified American Heart Association (AHA) classification and analysed for field strength-related differences. Weighted κ statistics were calculated to assess interobserver agreement.

Results: Interobserver agreement was substantial for nearly all categories. MRI at 3 T offered superior image quality in all contrast weightings, most significantly in T(1) and T(2) weighted techniques. Plaque burden in the study collective was unexpectedly moderate. The majority of plaques were classified as AHA III lesions; no lesions were classified above AHA V. There was no significant influence of the field strength regarding the AHA classification.

Conclusion: Abdominal aortal plaque screening is basically feasible at both field strengths, whereas the image quality is rated superior at 3 T. However, the role of the method in clinical practice remains uncertain, since substantial findings in the high-risk collective were scarce.

Citing Articles

Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions.

Fleg J, Stone G, Fayad Z, Granada J, Hatsukami T, Kolodgie F JACC Cardiovasc Imaging. 2012; 5(9):941-55.

PMID: 22974808 PMC: 3646061. DOI: 10.1016/j.jcmg.2012.07.007.

References
1.
Corti R, Fuster V, Fayad Z, Worthley S, Helft G, Smith D . Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002; 106(23):2884-7. DOI: 10.1161/01.cir.0000041255.88750.f0. View

2.
STARY H . Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol. 2000; 20(5):1177-8. DOI: 10.1161/01.atv.20.5.1177. View

3.
Sirol M, Fuster V, Fayad Z . Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med. 2006; 6(5):541-8. DOI: 10.2174/156652406778018617. View

4.
Skinner M, Yuan C, Mitsumori L, Hayes C, Raines E, Nelson J . Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1995; 1(1):69-73. DOI: 10.1038/nm0195-69. View

5.
Saam T, Hatsukami T, Takaya N, Chu B, Underhill H, Kerwin W . The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology. 2007; 244(1):64-77. DOI: 10.1148/radiol.2441051769. View